BioXcel Therapeutics (BTAI) Raw Materials (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Raw Materials of $408000.0 for Q1 2026, down 12.07% year-over-year from $464000.0 in Q1 2025, and up 28.71% quarter-over-quarter from $317000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Raw Materials (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Raw Materials history runs 5 years deep, the most recent figure standing at $408000.0 for Q1 2026.
- In Q1 2026, Raw Materials fell 12.07% year-over-year to $408000.0; the TTM figure through Mar 2026 stood at $408000.0 (down 12.07% YoY), while the FY2025 annual figure was $317000.0, down 37.35% from the prior year.
- Raw Materials for Q1 2026 stood at $408000.0, up from $317000.0 in the prior quarter.
- The five-year high for Raw Materials was $935000.0 in Q4 2023, with the low at $317000.0 in Q4 2025.
- The 5-year median for Raw Materials is $682000.0 (2022), against an average of $635625.0.
- The sharpest annual moves came in 2023 and 2025: Raw Materials surged 37.1% in 2023, then plunged 52.7% in 2025.
- BioXcel Therapeutics' Raw Materials stood at $682000.0 in 2022, then soared by 37.1% to $935000.0 in 2023, then slumped by 45.88% to $506000.0 in 2024, then slumped by 37.35% to $317000.0 in 2025, then climbed by 28.71% to $408000.0 in 2026.
- Business Quant data shows BTAI's Raw Materials at $408000.0 in Q1 2026, $317000.0 in Q4 2025, and $394000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn |
| 3 | Zoetis | 32.13 Bn | 30.45 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - |
| 10 | BioXcel Therapeutics | 25.36 Mn | 25.36 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 408,000.00 |
| Mar 31, 2026 | 408,000.00 |
| Dec 31, 2025 | 317,000.00 |
| Sep 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 464,000.00 |
| Dec 31, 2024 | 506,000.00 |
| Sep 30, 2024 | 833,000.00 |
| Jun 30, 2024 | 843,000.00 |
| Mar 31, 2024 | 935,000.00 |
| Dec 31, 2023 | 935,000.00 |
| Sep 30, 2023 | 682,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | 682,000.00 |
| Sep 30, 2022 | 682,000.00 |
| Jun 30, 2022 | 692,000.00 |